Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Genentech
Fierce Biotech
Roche oral SERD's 1st-line miss spurs new adjuvant trial
Roche plans to start a new study to test the combination of giredestrant with a CDK4/6 inhibitor for the adjuvant treatment of early breast cancer.
Angus Liu
Jun 2, 2026 12:45pm
Roche pips AstraZeneca for the top-rated cancer MSL team: survey
May 21, 2026 9:52am
Roche's Tecentriq nabs ctDNA-guided bladder cancer nod
May 15, 2026 3:23pm
Genentech taps Damon Wayans for ‘All Eyes on DME’ campaign
Apr 24, 2026 8:57am
Genentech shifts Hemlibra marketing focus to patient stories
Apr 20, 2026 9:30am
Genentech walks the walk in lupus as sponsor of annual event
Mar 26, 2026 11:20am
